173 related articles for article (PubMed ID: 26011546)
1. Health care resource utilization and costs associated with nonfatal major adverse cardiovascular events.
Korsnes JS; Davis KL; Ariely R; Bell CF; Mitra D
J Manag Care Spec Pharm; 2015 Jun; 21(6):443-50. PubMed ID: 26011546
[TBL] [Abstract][Full Text] [Related]
2. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
3. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
Lin J; Lingohr-Smith M; Kwong WJ
J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.
Lin I; Sung J; Sanchez RJ; Mallya UG; Friedman M; Panaccio M; Koren A; Neumann P; Menzin J
J Manag Care Spec Pharm; 2016 Jun; 22(6):685-98. PubMed ID: 27231796
[TBL] [Abstract][Full Text] [Related]
5. Cost of care for new versus recurrent acute coronary syndrome patients.
Shetty S; Halpern R; McCollam PL
J Med Econ; 2008; 11(1):81-99. PubMed ID: 19450112
[TBL] [Abstract][Full Text] [Related]
6. Total first-year costs of acute coronary syndrome in a managed care setting.
Etemad LR; McCollam PL
J Manag Care Pharm; 2005 May; 11(4):300-6. PubMed ID: 15871640
[TBL] [Abstract][Full Text] [Related]
7. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
[TBL] [Abstract][Full Text] [Related]
8. Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting.
Straka RJ; Liu LZ; Girase PS; DeLorenzo A; Chapman RH
Cardiovasc Diabetol; 2009 Sep; 8():53. PubMed ID: 19781099
[TBL] [Abstract][Full Text] [Related]
9. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
McCollam P; Etemad L
J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
[TBL] [Abstract][Full Text] [Related]
10. Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions.
Boklage SH; Malangone-Monaco E; Lopez-Gonzalez L; Ding Y; Henriques C; Elassal J
Cardiovasc Drugs Ther; 2018 Jun; 32(3):273-280. PubMed ID: 29855748
[TBL] [Abstract][Full Text] [Related]
11. Economic consequences of ACS-related rehospitalizations in the US.
Berenson K; Ogbonnaya A; Casciano R; Makenbaeva D; Mozaffari E; Lamerato L; Corbelli J
Curr Med Res Opin; 2010 Feb; 26(2):329-36. PubMed ID: 19968457
[TBL] [Abstract][Full Text] [Related]
12. Determining initial and follow-up costs of cardiovascular events in a US managed care population.
Chapman RH; Liu LZ; Girase PG; Straka RJ
BMC Cardiovasc Disord; 2011 Mar; 11():11. PubMed ID: 21410963
[TBL] [Abstract][Full Text] [Related]
13. The burden of major adverse cardiac events in patients with coronary artery disease.
Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
[TBL] [Abstract][Full Text] [Related]
14. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
[TBL] [Abstract][Full Text] [Related]
15. Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients?
Ulus T; Yildirir A; Sade LE; Temiz A; Polat E; Bozbaş H; Aydinalp A; Eroğlu S; Ozin B; Müderrisoğlu H
Coron Artery Dis; 2008 Nov; 19(7):489-95. PubMed ID: 18923245
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
Bullano MF; Willey V; Hauch O; Wygant G; Spyropoulos AC; Hoffman L
J Manag Care Pharm; 2005 Oct; 11(8):663-73. PubMed ID: 16194130
[TBL] [Abstract][Full Text] [Related]
17. Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes.
Xie G; Sun Y; Myint PK; Patel A; Yang X; Li M; Li X; Wu T; Li S; Gao R; Wu Y
Lipids Health Dis; 2017 Aug; 16(1):155. PubMed ID: 28810873
[TBL] [Abstract][Full Text] [Related]
18. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery.
Goodman SG; Aylward PE; Szarek M; Chumburidze V; Bhatt DL; Bittner VA; Diaz R; Edelberg JM; Hanotin C; Harrington RA; Jukema JW; Kedev S; Letierce A; Moryusef A; Pordy R; Ramos López GA; Roe MT; Viigimaa M; White HD; Zeiher AM; Steg PG; Schwartz GG;
J Am Coll Cardiol; 2019 Sep; 74(9):1177-1186. PubMed ID: 31466614
[TBL] [Abstract][Full Text] [Related]
19. Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome.
Rossello X; Ferreira JP; Caimari F; Lamiral Z; Sharma A; Mehta C; Bakris G; Cannon CP; White WB; Zannad F
Clin Res Cardiol; 2021 Oct; 110(10):1612-1624. PubMed ID: 33929598
[TBL] [Abstract][Full Text] [Related]
20. Outcomes associated with comorbid atrial fibrillation and heart failure in Medicare beneficiaries with acute coronary syndrome.
Chen SY; Crivera C; Stokes M; Boulanger L; Schein J
BMC Health Serv Res; 2014 Feb; 14():80. PubMed ID: 24555428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
